4.5 Article

Polycomb Group Protein Bmi1 Promotes Hematopoietic Cell Development from Embryonic Stem Cells

Journal

STEM CELLS AND DEVELOPMENT
Volume 21, Issue 1, Pages 121-132

Publisher

MARY ANN LIEBERT INC
DOI: 10.1089/scd.2010.0539

Keywords

-

Funding

  1. [SPP1356]

Ask authors/readers for more resources

Bmi1 is a component of the Polycomb repressive complexes and essential for maintaining the pool of adult stem cells. Polycomb repressive complexes are key regulators for embryonic development by modifying chromatin architecture and maintaining gene repression. To assess the role of Bmi1 in pluripotent stem cells and on exit from pluripotency during differentiation, we studied forced Bmi1 expression in mouse embryonic stem cells (ESC). We found that ESC do not express detectable levels of Bmi1 RNA and protein and that forced Bmi1 expression had no obvious influence on ESC self-renewal. However, upon ESC differentiation, Bmi1 effectively enhanced development of hematopoietic cells. Global transcriptional profiling identified a large array of genes that were differentially regulated during ESC differentiation by Bmi1. Importantly, we found that Bmi1 induced a prominent up-regulation of Gata2, a zinc finger transcription factor, which is essential for primitive hematopoietic cell generation from mesoderm. In addition, Bmi1 caused sustained growth and a >100-fold expansion of ESC-derived hematopoietic stem/progenitor cells within 2-3 weeks of culture. The enhanced proliferative capacity was associated with reduced Ink4a/Arf expression in Bmi1-transduced cells. Taken together, our experiments demonstrate distinct activities of Bmi1 in ESC and ESC-derived hematopoietic progenitor cells. In addition, Bmi1 enhances the propensity of ESC in differentiating toward the hematopoietic lineage. Thus, Bmi1 could be a candidate gene for engineered adult stem cell derivation from ESC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The metalloprotease ADAM10 generates soluble interleukin-2 receptor alpha (sCD25) in vivo

Sophia Kirschke, Ireti Ogunsulire, Balachandar Selvakumar, Neele Schumacher, Tanya Sezin, Stefan Rose-John, Alexander Scheffold, Christoph Garbers, Juliane Lokau

Summary: The cytokine IL-2 plays a crucial role in immune homeostasis. This study demonstrates that metalloproteases ADAM10 and ADAM17 can cleave the IL-2R alpha, generating a soluble ectodomain that inhibits IL-2 signaling in T cells. Manipulating the cleavage of IL-2R alpha offers a potential opportunity to alter IL-2 function.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Phagosomal signalling of the C-type lectin receptor Dectin-1 is terminated by intramembrane proteolysis

Torben Mentrup, Anna Yamina Stumpff-Niggemann, Nadja Leinung, Christine Schlosser, Katja Schubert, Rebekka Wehner, Antje Tunger, Valentin Schatz, Patrick Neubert, Ann-Christine Gradtke, Janina Wolf, Stefan Rose-John, Paul Saftig, Alexander Dalpke, Jonathan Jantsch, Marc Schmitz, Regina Fluhrer, Ilse D. Jacobsen, Bernd Schroeder

Summary: Dectin-1 plays a critical role in recognizing fungal pathogens through pattern recognition receptors on immune cells. Activation of Dectin-1a results in the formation of a stable receptor fragment lacking the ligand binding domain, which contributes to signal transduction in phagosomal membranes and is terminated by intramembrane proteases SPPL2a and 2b.

NATURE COMMUNICATIONS (2022)

Article Immunology

Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

Maria Angeles Rodriguez-Hernandez, David Carneros, Maria Nunez-Nunez, Ramon Coca, Rosario Baena, Gema M. Lopez-Ruiz, Maria Elena Cano-Serrano, Alberto Martinez-Telleria, Ana Fuentes-Lopez, Juan Manuel Praena-Fernandez, Christoph Garbers, Jose Hernandez-Quero, Federico Garcia, Stefan Rose-John, Matilde Bustos

Summary: IL-6 signaling variables serve as useful tools for early identification and stratification of COVID-19 patients, with significant implications for treatment and clinical decision-making.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

IL-6 Responsiveness of CD4+ and CD8+ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy

Tor Henrik Anderson Tvedt, Stefan Rose-John, Galina Tsykunova, Aymen Bushra Ahmed, Tobias Gedde-Dahl, Elisabeth Ersvaer, Oystein Bruserud

Summary: Graft-versus-host disease (GVHD) is a common complication after stem cell transplantation and is mediated by T cells. IL-6 plays a role in both pro-inflammatory and anti-inflammatory effects, and it modulates T cell response. The study found that CD3(+)CD4(+) and CD3(+)C8(+) T cells have different responses to IL-6 signaling, and these responses are influenced by antithymocyte globulin treatment. These findings suggest that IL-6 targeting after transplantation may have varied effects on patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, Research & Experimental

Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitis

Mor Paldor, Orr Levkovitch-Siany, Dana Eidelshtein, Revital Adar, Claes D. Enk, Yitzhak Marmary, Sharona Elgavish, Yuval Nevo, Hadar Benyamini, Inbar Plaschkes, Shiri Klein, Alex Mali, Stefan Rose-John, Amnon Peled, Eithan Galun, Jonathan H. Axelrod

Summary: This study reveals the molecular and cellular basis of irradiation-induced alopecia and dermatitis (IRIAD). Senescence-associated IL-6 and IL-1 signaling, IL-17 upregulation, and CCR6(+)-mediated immune cell migration are the key drivers of IRIAD. Genetic ablation and molecular inhibition of these pathways alleviate IRIAD symptoms.

EMBO MOLECULAR MEDICINE (2022)

Article Pharmacology & Pharmacy

Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc)

Dominik M. Schulte, Georg H. Waetzig, Harald Schuett, Marlies Marx, Berenice Schulte, Christoph Garbers, Juliane Lokau, Ann-Kathrin Vlacil, Juliane Schulz, Anna K. Seoudy, Bernhard Schieffer, Philip Rosenstiel, Marcus Seeger, Matthias Laudes, Stefan Rose-John, Ulf Luetzen, Karsten Grote, Stefan Schreiber

Summary: Inflammation plays an important role in atherosclerotic cardiovascular disease, and there is a need for therapies targeting excessive inflammation. A fusion protein called olamkicept has been shown to reduce atherosclerosis independently of LDL cholesterol metabolism in mice, and its use in a patient with high-risk ASCVD also demonstrated a reduction in arterial wall inflammation.

FRONTIERS IN PHARMACOLOGY (2022)

Article Immunology

The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation

Aikaterini Gatsiou, Simon Tual-Chalot, Matteo Napoli, Almudena Ortega-Gomez, Tommy Regen, Rachit Badolia, Valeriana Cesarini, Claudia Garcia-Gonzalez, Raphael Chevre, Giorgia Ciliberti, Carlos Silvestre-Roig, Maurizio Martini, Jedrzej Hoffmann, Rana Hamouche, Joseph R. Visker, Nikolaos Diakos, Astrid Wietelmann, Domenico Alessandro Silvestris, Georgio Georgiopoulos, Ali Moshfegh, Andre Schneider, Wei Chan, Stefan Guenther, Johanne Backs, Shin Kwak, Craig H. Selzman, Kimon Stamatelopoulos, Stefan Rose-John, Christian Trautwein, Ioakim Spyridopoulos, Thomas Braun, Ari Waisman, Angela Gallo, Stavros G. Drakos, Stefanie Dimmeler, Markus Sperandio, Oliver Soehnlein, Konstantinos Stellos

Summary: RNA editor ADAR2 regulates endothelial responses to IL-6, controlling leukocyte trafficking in inflamed and ischemic tissues. ADAR2 is required for IL-6 trans-signaling and immune cell infiltration through suppressing primary microRNA processing.

IMMUNITY (2023)

Article Neurosciences

The Alzheimer's disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130

Stephan A. Muller, Merav D. Shmueli, Xiao Feng, Johanna Tushaus, Neele Schumacher, Ryan Clark, Brad E. Smith, An Chi, Stefan Rose-John, Matthew E. Kennedy, Stefan F. Lichtenthaler

Summary: In this study, the researchers identified SEZ6 and gp130/IL6ST as physiological substrates of BACE1 in non-human-primate cerebrospinal fluid. They also found a reduction of gp130 in human CSF from a clinical trial with a BACE inhibitor and in plasma of BACE1-deficient mice. These findings provide insights into the relationship between BACE1 and gp130 in neuronal signaling and survival.

MOLECULAR NEURODEGENERATION (2023)

Article Immunology

Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model

Agatha Schwarz, Rebecca Philippsen, Serena G. Piticchio, Jan N. Hartmann, Robert Haesler, Stefan Rose-John, Thomas Schwarz

Summary: The organ-specific microbiome, particularly the skin microbiome, plays a crucial role in tissue homeostasis by regulating the inflammatory response. Short chain fatty acids (SCFA) induce regulatory T cells (Treg) in the skin and their signal is mediated by the receptor HCA2. Knock-out of HCA2 results in stronger inflammation and a switch of Treg from a suppressive to a proinflammatory type, indicating that the skin microbiome dictates the outcome of the inflammatory reaction.

FRONTIERS IN IMMUNOLOGY (2023)

Review Immunology

Targeting IL-6 trans-signalling: past, present and future prospects

Stefan Rose-John, Brendan J. Jenkins, Christoph Garbers, Jens M. Moll, Juergen Scheller

Summary: This review discusses the discovery of the IL-6 trans-signalling pathway and the development of biologics that specifically inhibit this pathway. Targeting IL-6 trans-signalling can decrease disease-promoting activities of IL-6 without blocking its protective actions.

NATURE REVIEWS IMMUNOLOGY (2023)

Meeting Abstract Immunology

The role of ADAM10 in the regulation of T cell responses

P. Bradtke, J. Roesch, D. Reimers, K. Yan, S. Rose-John, H. -W. Mittruecker

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Meeting Abstract Immunology

Sustained gp130 signaling in T cells causes unrestricted TH17 cell responses and severe lung inflammation

E. V. M. Huth, L. C. Heinig, K. Yan, P. Bradtke, N. Lory, T. Wiech, S. Rose-John, H. -W. Mittruecker

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Meeting Abstract Oncology

NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy

Melanie Spitzner, Kristin Koerdel, Thomas Meyer, Niklas Engels, Florian Krause, Jochen Gaedcke, Lena-Christin Conradi, Martin Haubrock, Tim Beissbarth, Andreas Leha, Steven A. Johnsen, B. Michael Ghadimi, Stefan Rose-John, Jurgen Wienands, Marian Grade

ONCOLOGY RESEARCH AND TREATMENT (2022)

Meeting Abstract Ophthalmology

Clinical and functional effect of intravitreal injection of anti-IL-6 antibody on experimental autoimmune uveitis (EAU) in mice

Kristin Hoesel, Buesra Chasan, Christoph Ehlken, Jan Tode, Stefan Rose-John, Johann Roider

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

Meeting Abstract Gastroenterology & Hepatology

Mixed HCC-CCA originates from hepatic progenitor cells, is dependent on IL6 singling and is ablated by senolytic agents

Nofar Rosenberg, Matthias Van Haele, Maria Garcia Beccaria, Mirian Fernandez-Vaquero, Danijela Heide, Neta Barashi, Amnon Peled, Yuval Nevo, Shrona Elgavish, Dirk Schmist-Arras, Hanan Edler, Alina Simerzin, Michal Shoshkes-Carmel, Klaus Kaestner, Hilla Giladi, Stefan Rose-John, Tania Roskams, Mathias Heikenwalder, Eithan Galun

JOURNAL OF HEPATOLOGY (2022)

No Data Available